查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511833

潛伏性結核感染檢測市場規模、佔有率和趨勢分析報告：按品牌、測試類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

潛伏性結核感染檢測市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球潛伏性結核感染檢測市場規模預計將達到 26.3 億美元。

預計2024年至2030年該市場將以5.44%的複合年成長率擴張。潛伏性結核感染疾病（LTBI）導致活動性疾病的風險不斷增加，加上全球老年人口的快速增加，是市場成長的主要驅動力之一。此外，人們對結核病檢測的認知不斷提高，以及政府為有效診斷和篩檢結核病感染而採取的各種舉措，也是促進市場擴張的因素之一。例如，2021 年 7 月，UKHSA 和英格蘭 NHS 啟動了一項減少該國結核病病例的五年計畫。

市場成長的驅動力是全球老年人口的增加。例如，根據美國健康排名2021年老年人口報告，美國65歲以上人口超過5,400萬，佔全國人口的16.5%。老年人更容易感染潛伏性結核病。政策制定者和公共衛生官員正在改善政策，以改善全國老年人的健康。

此外，主要組織為促進結核病診斷和檢測而持續提供的財政支持也有望促進市場成長。例如，Unitaid 是一家領先的衛生組織，致力於尋找疾病的快速解決方案。 2022 年 9 月，國際藥品採購機制啟動了 3,000 萬美元的資助，以加速結核病檢測。這筆資金將支持當日檢測的開發，也將有助於開發新的結核病診斷技術。

同樣，全球基金為控制結核病、瘧疾和愛滋病毒等感染疾病提供支持和資金。該組織為結核病防治提供了全球約76%的資金，並在結核病控制方面投資約85億美元。此外，2021 年 8 月，全球基金向 FIND 提供資金，以加速印度的結核病診斷和預防。這項投資最佳化了結核病早期診斷實驗室的質量，提高了國家結核病診斷能力。

此外，增加全球檢測工作以促進結核病感染的診斷預計將支持市場擴張。例如，QIAGEN NV 於 2022 年 3 月宣布，自推出以來已售出 1 億份 QuantiFERON 血液檢測。此後，該公司決定擴大規模，將 QuantiFERON 帶給世界各地更多的患者。此外，各大公司為擴大市場佔有率所採取的各種策略性措施也是推動市場擴張的因素之一。例如，2021 年 10 月，QIAGEN 宣布獲得 CE 標誌核准，並部署用於診斷結核感染的 QIAreach QuantiFERON-TB 測試。

潛伏性結核感染檢測市場報告重點：

  • 按測試類型分類，由於各公共衛生機構對 IGRA 的建議不斷增加，預計 IGRA 產業在預測期內將以最快的速度成長。
  • 從應用來看，由於愛滋病毒感染者罹患結核病的風險增加，愛滋病毒感染者在 2023 年佔據了最大的銷售佔有率。
  • 診斷實驗室部門是 2023 年收益貢獻最大的部門。另一方面，學術和研究機構部門預計在預測期內將呈現最快的複合年成長率。
  • 由於市場參與企業增加投資和研究活動活性化，預計亞太地區將在預測期內呈現最快的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章潛伏性結核感染檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 市場機會分析
    • 未滿足需求分析
  • 潛伏性結核感染檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析
    • 定量分析

第4章潛伏性結核感染檢測市場：品牌評估與趨勢分析

  • 全球潛伏性結核感染檢測市場：品牌儀表板
  • 全球潛伏性結核感染檢測市場：品牌變化分析
  • 全球潛伏性結核感染檢測市場：依品牌、按收益
  • QFT-Plus（Quantiferon TB Gold Plus）
  • 其他

第5章潛伏性結核感染檢測市場：檢測類型的估算與趨勢分析

  • 全球潛伏性結核感染檢測市場：測試類型儀表板
  • 全球潛伏性結核感染檢測市場：測試類型變異分析
  • 全球潛伏性結核感染檢測市場：按測試類型和收益
  • 結核菌素皮膚試驗（TST）
  • 干擾素γ釋放測定（IGRA）

第6章潛伏性結核感染檢測市場：應用估計與趨勢分析

  • 全球潛伏性結核感染檢測市場：應用儀表板
  • 全球潛伏性結核感染檢測市場：應用變化分析
  • 全球潛伏性結核感染檢測市場：按應用和收益
  • 家庭接觸結核病
  • 愛滋病毒感染者
  • 其他

第7章潛伏性結核感染檢測市場：最終用途估計與趨勢分析

  • 全球潛伏性結核感染檢測市場：最終用途儀表板
  • 全球潛伏性結核感染檢測市場：最終用途變化分析
  • 全球潛伏性結核感染檢測市場：依最終用途、按收益
  • 診斷實驗室
  • 醫院/診所
  • 學術/研究機構

第8章潛伏性結核感染檢測市場：按產品類型、技術和最終用途進行的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場占有率分析
    • QIAGEN
    • BIOMERIEUX
    • Oxford Immunotec
    • SD Biosensor, INC.
    • Wantai BioPharm
    • Lionex GmbH
    • Sanofi
    • Serum Institute of India Pvt. Ltd
    • ARKRAY, Inc.
    • Par Pharmaceutical, Inc.
Product Code: GVR-4-68039-994-9

Latent Tuberculosis Infection Detection Market Growth & Trends:

The global latent tuberculosis infection detection market size is expected to reach USD 2.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.44% from 2024 to 2030. The increased risk of developing active disease from latent tuberculosis infection (LTBI) coupled with the surge in the geriatric population globally is one of the major driving factors for the market growth. In addition, rising awareness about TB detection and various government initiatives for effective diagnosis and screening of tuberculosis infection is another factor contributing to market expansion. For instance, in July 2021, the UKHSA and NHS of England launched a 5-year plan to decrease TB cases in the country.

The market growth is fueled by the increase in the geriatric population across the globe. For instance, according to the elderly population report of America's Health Rankings 2021, more than 54 million population aged more than 65 years in the U.S. which accounts for 16.5% of the country's population. The geriatric population is highly susceptible to developing latent TB infection. Policymakers and public health officials are making improvements in policies to improve the health of older in the country.

Furthermore, ongoing funding activities by leading organizations to promote the diagnosis and testing for tuberculosis are also expected to fuel market growth. For instance, Unitaid is a leading health agency engaged in discovering quick solutions for diseases. In September 2022, the Unitaid launched funding of USD 30 million to boost tuberculosis detection. This funding will support the development of same-day tests and also help in the development of novel diagnostic technologies for tuberculosis.

Similarly, the Global Fund provides support and funding for the management of infectious diseases such as tuberculosis, malaria, and HIV. The organization provides around 76% of global financing for tuberculosis and it has invested around USD 8.5 billion for the management of tuberculosis. Furthermore, in August 2021, the Global Fund provide funds to FIND for the advancement of TB diagnosis and prevention in India. This investment optimized laboratory quality for early diagnosis of TB and improved tuberculosis diagnostic capacity in the country.

In addition, the rising testing efforts globally to promote the diagnosis of TB infection are expected to support market expansion. For instance, in March 2022, QIAGEN N.V. announced that the company has sold 100 million QuantiFERON blood tests since its launch. After this, the company decided to expand QuantiFERON to reach more patients across the globe. Moreover, various strategic initiatives undertaken by leading players to enhance their market share are another factor facilitating market expansion. For instance, in October 2021, QIAGEN announced CE mark approval and roll-out of the QIAreach QuantiFERON-TB test for tuberculosis infection diagnosis.

Latent Tuberculosis Infection Detection Market Report Highlights:

  • In test type, the IGRA segment is expected to grow at the fastest rate over the forecast period owing to increasing recommendations for IGRAs from various public health authorities
  • Based on application segment, the PLHIV accounted for the largest revenue share in 2023 due to the rising risk of developing TB in people suffering from HIV infection
  • The diagnostic laboratories segment was the highest revenue contributor in 2023. Whereas the academic and research institutions segment is expected to exhibit the fastest CAGR during the projected period
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Brand
    • 1.2.2. Test Type
    • 1.2.3. Application
    • 1.2.4. End-use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Brand and test type outlook
    • 2.2.2. Application and end-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing risk of developing active tuberculosis infection from LTBI
      • 3.2.1.2. Increasing funding programs to promote TB diagnosis
      • 3.2.1.3. Favorable government initiatives for combating TB
      • 3.2.1.4. Surge in geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent rules and regulations pertaining to diagnosis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Unmet need analysis
  • 3.3. Latent Tuberculosis Infection Detection Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environment landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Volume Analysis

Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis

  • 4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
  • 4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
  • 4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
  • 4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
    • 4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Latent Tuberculosis Infection Detection Market: Test Type Estimates & Trend Analysis

  • 5.1. Global Latent Tuberculosis Infection Detection Market: Test Type Dashboard
  • 5.2. Global Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
  • 5.3. Global Latent Tuberculosis Infection Detection Market by Test Type, Revenue
  • 5.4. Tuberculin Skin Test (TST)
    • 5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Interferon Gamma Released Assay (IGRA)
    • 5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis

  • 6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
  • 6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
  • 6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
  • 6.4. Household Contacts with Pulmonary TB
    • 6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. PLHIV
    • 6.5.1. PLHIV market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Latent Tuberculosis Infection Detection Market: End-use Estimates & Trend Analysis

  • 7.1. Global Latent Tuberculosis Infection Detection Market: End-use Dashboard
  • 7.2. Global Latent Tuberculosis Infection Detection Market: End-use Movement Analysis
  • 7.3. Global Latent Tuberculosis Infection Detection Market by End-use, Revenue
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals/Clinics
    • 7.5.1. Hospitals/Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Academic & research institutions market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End-use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.9. Netherlands
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.10. Belgium
      • 8.4.10.1. Key country dynamics
      • 8.4.10.2. Regulatory framework/ reimbursement structure
      • 8.4.10.3. Competitive scenario
      • 8.4.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.11. Finland
      • 8.4.11.1. Key country dynamics
      • 8.4.11.2. Regulatory framework/ reimbursement structure
      • 8.4.11.3. Competitive scenario
      • 8.4.11.4. Finland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.12. Luxembourg
      • 8.4.12.1. Key country dynamics
      • 8.4.12.2. Regulatory framework/ reimbursement structure
      • 8.4.12.3. Competitive scenario
      • 8.4.12.4. Luxembourg market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.13. Iceland
      • 8.4.13.1. Key country dynamics
      • 8.4.13.2. Regulatory framework/ reimbursement structure
      • 8.4.13.3. Competitive scenario
      • 8.4.13.4. Iceland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.7. Singapore
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.8. Bangladesh
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Bangladesh market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.6.2. Mexico
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. QIAGEN
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. BIOMERIEUX
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Oxford Immunotec
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. SD Biosensor, INC.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Wantai BioPharm
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Lionex GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Sanofi
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Serum Institute of India Pvt. Ltd
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. ARKRAY, Inc.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Par Pharmaceutical, Inc.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 3 North America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 4 North America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 5 North America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 6 North America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 7 U.S. latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 8 U.S. latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 9 U.S. latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 10 U.S. latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 11 Canada latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 12 Canada latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 13 Canada latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 14 Canada latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 15 Europe latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 16 Europe latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 17 Europe latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 18 Europe latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 19 Europe latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 20 Germany latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 21 Germany latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 22 Germany latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 23 Germany latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 24 UK latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 25 UK latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 26 UK latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 27 UK latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 28 France latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 29 France latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 30 France latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 31 France latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 32 Italy latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 33 Italy latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 34 Italy latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 35 Italy latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 36 Spain latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 37 Spain latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 38 Spain latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 39 Spain latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 40 Denmark latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 41 Denmark latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 42 Denmark latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 43 Denmark latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 44 Sweden latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 45 Sweden latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 46 Sweden latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 47 Sweden latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 48 Norway latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 49 Norway latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 50 Norway latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 51 Norway latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 52 Netherlands latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 53 Netherlands latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 54 Netherlands latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 55 Netherlands latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 56 Belgium latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 57 Belgium latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 58 Belgium latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 59 Belgium latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 60 Finland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 61 Finland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 62 Finland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 63 Finland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 64 Luxembourg latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 65 Luxembourg latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 66 Luxembourg latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 67 Luxembourg latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 68 Iceland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 69 Iceland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 70 Iceland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 71 Iceland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 72 Asia Pacific latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 73 Asia Pacific latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 74 Asia Pacific latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 75 Asia Pacific latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 76 Aisa Pacific latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 77 China latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 78 China latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 79 China latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 80 China latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 81 Japan latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 82 Japan latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 83 Japan latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 84 Japan latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 85 India latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 86 India latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 87 India latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 88 India latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 89 South Korea latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 90 South Korea latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 91 South Korea latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 92 South Korea latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 93 Australia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 94 Australia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 95 Australia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 96 Australia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 97 Thailand latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 98 Thailand latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 99 Thailand latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 100 Thailand latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 101 Singapore latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 102 Singapore latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 103 Singapore latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 104 Singapore latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 105 Bangladesh latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 106 Bangladesh latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 107 Bangladesh latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 108 Bangladesh latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 109 Latin America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 110 Latin America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 111 Latin America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 112 Latin America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 113 Latin America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 114 Brazil latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 115 Brazil latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 116 Brazil latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 117 Brazil latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 118 Mexico latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 119 Mexico latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 120 Mexico latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 121 Mexico latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 122 Argentina latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 123 Argentina latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 124 Argentina latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 125 Argentina latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 126 MEA latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 127 MEA latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 128 MEA latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 129 MEA latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 130 MEA latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 131 South Africa latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 132 South Africa latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 133 South Africa latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 134 South Africa latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 135 Saudi Arabia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 136 Saudi Arabia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 137 Saudi Arabia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 138 Saudi Arabia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 139 UAE latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 140 UAE latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 141 UAE latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 142 UAE latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 143 Kuwait latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 144 Kuwait latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 145 Kuwait latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 146 Kuwait latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Latent tuberculosis infection detection market: market outlook
  • Fig. 14 Latent tuberculosis infection detection competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Latent tuberculosis infection detection market driver impact
  • Fig. 18 Latent tuberculosis infection detection market restraint impact
  • Fig. 19 Latent tuberculosis infection detection market: Brand movement analysis
  • Fig. 20 Latent tuberculosis infection detection market: Brand outlook and key takeaways
  • Fig. 21 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 22 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 23 Latent tuberculosis infection detection market: Test type movement analysis
  • Fig. 24 Latent tuberculosis infection detection market: Test type outlook and key takeaways
  • Fig. 25 Tuberculin Skin Test (TST) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 26 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 27 Latent tuberculosis infection detection market: Application movement analysis
  • Fig. 28 Latent tuberculosis infection detection market: Application outlook and key takeaways
  • Fig. 29 Household contacts with pulmonary TB market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 30 PLHIV estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 31 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 32 Latent tuberculosis infection detection market: End-use movement analysis
  • Fig. 33 Latent tuberculosis infection detection market: End-use outlook and key takeaways
  • Fig. 34 Diagnostics laboratories estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 35 Hospital/Clinics market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 36 Academic & research institutions market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 37 Global latent tuberculosis infection detection market: Regional movement analysis
  • Fig. 38 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
  • Fig. 39 Global latent tuberculosis infection detection market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 57 Denmark key country dynamics
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 59 Sweden key country dynamics
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 61 Norway key country dynamics
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 63 Netherlands key country dynamics
  • Fig. 64 Netherlands market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 65 Belgium key country dynamics
  • Fig. 66 Belgium market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 67 Finland key country dynamics
  • Fig. 68 Finland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 69 Luxembourg key country dynamics
  • Fig. 70 Luxembourg market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 71 Iceland key country dynamics
  • Fig. 72 Iceland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 74 China key country dynamics
  • Fig. 75 China market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 76 Japan key country dynamics
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 78 India key country dynamics
  • Fig. 79 India market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 80 Thailand key country dynamics
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 82 South Korea key country dynamics
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 84 Australia key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 86 Singapore key country dynamics
  • Fig. 87 Singapore market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 88 Bangladesh key country dynamics
  • Fig. 89 Bangladesh market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 90 Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 91 Brazil key country dynamics
  • Fig. 92 Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 93 Mexico key country dynamics
  • Fig. 94 Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 95 Argentina key country dynamics
  • Fig. 96 Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 97 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 98 South Africa key country dynamics
  • Fig. 99 South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 100 Saudi Arabia key country dynamics
  • Fig. 101 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 102 UAE key country dynamics
  • Fig. 103 UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 104 Kuwait key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 106 Market share of key market players - Latent tuberculosis infection detection market